Steve Horvath | From clocks to care: epigenetics in precision medicine | Milan Longevity Summit 2026

Can epigenetic clocks change the way medicine is practised? In this session from *Measuring Ageing: Biomarkers, Clocks, and Predictive Tools at the Milan Longevity Summit 2026, Professor Steve Horvath explores how epigenetic clocks are moving beyond research laboratories to become practical tools for precision medicine.* As the pioneer of the first widely adopted epigenetic clock, Professor Horvath examines how DNA methylation biomarkers can measure biological age, predict disease risk, evaluate the effectiveness of interventions, and help personalise healthcare. The discussion explores how these powerful technologies are reshaping our understanding of ageing and bringing us closer to a future where prevention and treatment are tailored to each individual's biological profile. *Professor Steve Horvath is Principal Investigator at the University of California, Los Angeles (UCLA)* and one of the world's leading pioneers in epigenetics and ageing research. His groundbreaking development of the Horvath Epigenetic Clock revolutionised the field by providing one of the first robust methods to estimate biological age from DNA methylation patterns. Today, his work continues to drive advances in longevity science, biomarker discovery, and precision medicine. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a One Health perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. Learn more about the Milan Longevity Summit: https://www.milanlongevitysummit.org/it/speakers26/steve-horvath #MilanLongevitySummit #Longevity #OneHealth #SteveHorvath #Epigenetics #EpigeneticClock #BiologicalAge #PrecisionMedicine #HealthyAgeing #Healthspan